Jacob Hummel M.D. Tulane University Anesthesiology.

Slides:



Advertisements
Similar presentations
Role of anticholinergic therapy in COPD Adil Al Sulami Medical Resident KAUH.
Advertisements

INDIRECT CHOLINOMIMETICS Pharmacology Department
DIRECT CHOLINERGIC DRUGS Pharmacology Department
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 15 Cholinesterase Inhibitors and Their Use in Myasthenia Gravis.
INDIRECT CHOLINOMIMETICS
Cholinergic-Blocking Drugs
Pharmacology-1 PHL 313 Parasympathetic Nervous System
Pharmacology-1 PHL 313 Parasympathetic Nervous System Third Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacology DOR 101 Abdelkader Ashour, Ph.D. 5 th Lecture.
ANTICHOLINERGIC DRUGS Pharmacology Department
1. 2 Cholinoceptor-Blocking Drugs Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology.
Chapter 5 Autonomic Drugs.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.
CHAPTER 21 Cholinergic-Blocking Drugs
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 7 Anticholinergic (Parasympatholytic) Bronchodilators.
Cholinergic agonists & Cholinergic antagonists
Cholinergics, anticholinergics and antcholinesterases Nervous System Peripheral NS Sensory nerves Motor nerves Central NS (Brain and Spinal cord) Sensory.
Cholinergic agonists By Dr.Sajid Hussain
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 20 Cholinergic-Blocking Drugs.
Autonomic Nervous System
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
Anticholinergic drugs Prof. Alhaider 1433 H Are drugs that block cholinergic receptors. Anticholinergic drugs.
Anticholinergics in COPD presented by: Soha Ragab Moselhy group 2.
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
INDIRECT CHOLINOMIMETICS
Chapter 33 Agents Affecting the Autonomic Nervous System.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 19 Cholinergic Drugs.
1 Cholinergic Receptors Antagonists Section 2, lecture 3.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 20 Cholinergic Drugs.
Cholinergic antagonists
Copyright © 2012, 2008, 2002, 1998, 1994, 1989, 1984, 1978 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 7 Anticholinergic (Parasympatholytic)
ANTICHOLINERGIC DRUGS
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
ANTICHOLINESTERASES Acetylcholinesterase is an enzyme that specifically cleaves acetylcholine to acetate and choline. It is located both pre-and post-synaptically.
Drugs Affecting the Autonomic Nervous System
AUTONOMIC NERVOUS SYSTEM LECTURE 6 PHARMACOLOGY. Autonomic Pharmacology Autonomic Nervous System – This system is divided into two separate systems. –
Muscarinic antagonists:- Naturally occurring atropine & hyoscine, homatropine.
Anticholinergic Drugs
Cholinergic antagonists Samuel Aguazim ( MD). What are cholinergic antagonists? Drugs that bind to cholinergic receptors ( muscarinic and/or nicotinic),
Cholinoceptor Blocking Agents Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)
INDIRECT CHOLINOMIMETICS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
HuBio 543 September 24, 2007 Neil M. Nathanson K-536A, HSB Muscarinic Antagonists.
PHARMACOLOGY REVIEW. What is Pharmacology ? Pharmacology Pharmacokinetics Pharmacodynamics What the body does to drug What the drug does to body Pharmacotherapeutics.
By Pharmacist Salwan Salem  -Central nervous system (CNS)  - Peripheral nervous system (PNS)  *CNS: spinal cord and brain  *The PNS consists.
Dr: Samah Gaafar Al-shaygi بسم الله الرحمن الرحيم.
Drugs Affecting Autonomic Nervous System 2. Drugs Affecting the Autonomic Nervous System Cholinergic Agents Cholinergic Blocking Agents.
Autonomic Nervous System Anticholinergic Drugs- 5
INDIRECT CHOLINOMIMETICS Prof. Hanan Hagar Pharmacology Department.
(Cholinergic antagonists) (Anticholinergic ) (Cholinergic Blockers)
Anticholinergic drugs
Cholinergic-Blocking Drugs
INDIRECT CHOLINOMIMETICS Pharmacology Department
INDIRECT CHOLINOMIMETICS
Neuromuscular blockers
Drugs Affecting Autonomic Nervous System 2
Anticholinergic Agents
Anticholinesterase Drugs and Cholinergic Agonists
Neurotransmitters SOMATIC NERVOUS SYSTEM Striated ACh muscle
Cholinergic Antagonist
Cholinergic Antagonist
Chapter 5 Autonomic Drugs.
INDIRECT CHOLINOMIMETICS
Intro to Neuromuscular blocking agents
ANTICHOLINERGIC DRUGS
Organophosphate poisoning
Intro to Neuromuscular blocking agents
Neuromuscular blockers
Cholinesterase inhibitors
Cholinesterase inhibitors
Copyright © 2011 by Elsevier Inc. All rights reserved.
Presentation transcript:

Jacob Hummel M.D. Tulane University Anesthesiology

* Know the different mechanisms of action for atropine, scopolamine and glycopyrrolate * Clinical use of each of these drugs * Effects on the cardiovascular, respiratory, cerebral, G.I. and other organ systems

* This is a really short lecture but its brevity does not reflect the value of its content

* This term is more indicative of what these drugs accomplish as they are primarily blocking the effects of acetylcholine at the muscarinic receptors

* Primary use is prior or concomitant administration with anticholinesterases * Crucial in the treatment of bradycardia * Beneficial in the prevention of PONV * Antisialogogues

*

* Ester linkage essential for effective binding to the acetylcholine receptors, competitively inhibiting the binding of acetylcholine * Different types of muscarinic receptors: neuronal (M1), cardiac (M2), and glandular (M3)

* CARDIOVASCULAR * Blockade of the muscarinic receptors in the sinoatrial node results in tachycardia * Useful for reversing vagal reflexes

* RESPIRATORY * Inhibit secretions along the respiratory tract * Relaxes bronchial smooth muscle -> decreased airway resistance but increased dead space

* CEREBRAL * Range of effects, stimulation to depression * Physostigmine reverses these occurrences

* G.I. * Decreased secretions and salivation * Decreased peristalsis * Lower esophageal sphincter pressure reduced …better view, but more at risk for aspiration

* Other Effects * Mydriasis * Urinary retention * Reduced sweating, rise in body temp

* Potent effects on the heart and lungs * Most efficacious for treating bradycardia * Tertiary amine allows it to cross blood-brain barrier * Derivative is ipratropium bromide and used to treat bronchospasm * Use cautiously with heart disease, narrow angle glaucoma, BPH and bladder-neck obstruction Give me the atropine, NOW!

* Similar dosing to atropine, mg/kg with adult dose around mg * More potent antisialogogue than atropine * Greater CNS effects * Lipid solubility allows for the transdermal patch * Don’t touch your eyes after you put a patch on someone!

* Contains mandelic acid in place of the tropic acid seen in atropine * Dosing is usually half of the atropine dosing and used for similar effects (bradycardia, antisialogogue, etc.) * Quaternary structure prevents crossing of the blood- brain barrier * No ophthalmic activity * Potent antisialogogue * Longer duration of action than atropine (2-4 hrs. vs 30 minutes)

* An elderly patient is scheduled for enucleation of a blind, painful eye. Scopolamine, 0.4 mg intramuscularly, is administered as premedication. In the preoperative holding area, the patient becomes agitated and disoriented The only other medication the patient has received is 1% atropine eye drops * …how do you treat and would you proceed with the case?

* Signs and Symptoms * Agitation, delirium, unconsciousness * dry mouth, tachycardia, atropine flush, atropine fever, and impaired vision …antidote is physostigmine as it is the only anticholinesterase to cross the blood-brain barrier

* Elective Procedure * Is patient optimally medically managed? * Do symptoms resolve with intervention?

* GENERAL HUMMEL FROM ALCATRAZ….OUT!